Acadia Healthcare CEO Christopher Hunter Departs Company, Board

Acadia Healthcare ( (ACHC) ) has provided an update.

On January 20, 2026, Acadia Healthcare Company, Inc. announced that Chief Executive Officer Christopher H. Hunter departed from his role and simultaneously resigned from the company’s board of directors, with both changes effective that same day. Under a separation and release agreement, Hunter will remain eligible for his 2025 annual bonus and will receive severance equal to 1.5 times his base salary plus target 2025 bonus, paid over 18 months, 18 months of after-tax health and dental premium support, a $1,785,000 lump-sum cash retention bonus, and the continued vesting eligibility of a prorated portion of his performance-based restricted stock units based on actual future performance, while all other unvested equity awards were forfeited; these benefits are contingent on his release of claims and compliance with restrictive covenants.

The most recent analyst rating on (ACHC) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Acadia Healthcare stock, see the ACHC Stock Forecast page.

Spark’s Take on ACHC Stock

According to Spark, TipRanks’ AI Analyst, ACHC is a Neutral.

The score is led by solid financial fundamentals (revenue growth and improved gross margin) and a modest P/E, but is held back by weaker profitability, higher leverage, and a technically soft setup (below key longer-term moving averages with negative MACD). The latest earnings update and leadership change add near-term uncertainty due to lowered EBITDA guidance, partially offset by reaffirmed outlook and capacity expansion plans.

To see Spark’s full report on ACHC stock, click here.

More about Acadia Healthcare

Average Trading Volume: 3,202,932

Technical Sentiment Signal: Sell

Current Market Cap: $1.31B

For detailed information about ACHC stock, go to TipRanks’ Stock Analysis page.